RA Capital Management Announces Close of $1.4 Billion Acquisition of Aliada Therapeutics by AbbVie
Closing marks second significant acquisition from RA Capital's Raven incubator in 2024, and first acquisition of a company built by Raven from a technology platform in-licensed from a large pharmaceutical